You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

seroquel XR

Showing 1 - 25 of 531
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Bipolar Disorder Therapies

Completed
  • Bipolar Disorder
  • Lithium Carbonate
  • +29 more
  • Albuquerque, New Mexico
    Christophe G Lambert
Sep 29, 2021

MDD Trial in Hokkaidou, Kantou, Kinki (quetiapine extended release (XR), Placebo)

Completed
Has Results
  • Major Depressive Disorder
  • quetiapine extended release (XR)
  • Placebo
  • Hokkaidou, Japan
  • +2 more
Jul 19, 2019

Schizophrenia Trial in Worldwide (SEP363856, quetiapine XR)

Active, not recruiting
  • Schizophrenia
  • Cerritos, California
  • +45 more
Feb 16, 2022

Multiple Sclerosis Trial in Calgary (Extended-release quetiapine fumarate)

Completed
  • Multiple Sclerosis
  • Extended-release quetiapine fumarate
  • Calgary, Alberta, Canada
    MS Clinic, Foothills Medical Centre
Oct 6, 2019

Schizophrenia, Schizoaffective Disorder Trial in Long Beach (Lu AF35700 (10 mg/day), Lu AF35700 (30 mg/day), Quetiapine

Completed
  • Schizophrenia
  • Schizoaffective Disorder
  • Lu AF35700 (10 mg/day)
  • +2 more
  • Long Beach, California
    US1104
Sep 11, 2019

Alcoholism, Alcohol Abuse Trial in United States (Quetiapine fumarate, Placebo)

Completed
Has Results
  • Alcoholism
  • Alcohol Abuse
  • Quetiapine fumarate
  • Placebo
  • Boston, Massachusetts
  • +6 more
Feb 26, 2019

Opiate Withdrawal Syndrome, Opioid Use Trial in Philadelphia (LFX/PGB, LFX/PLA-PGB)

Not yet recruiting
  • Opiate Withdrawal Syndrome
  • Opioid Use
  • Philadelphia, Pennsylvania
    University of Pennsylvania, Treatment Research Center
Aug 18, 2023

Opioid-Related Disorders, Substance-Related Disorders, Narcotic-Related Disorders Trial in United States (Injectable

Not yet recruiting
  • Opioid-Related Disorders
  • +2 more
  • Injectable extended-release buprenorphine
  • Sublingual buprenorphine-naloxone
  • Garberville, California
  • +5 more
Aug 28, 2023

Opioid-use Disorder Trial in Loerenskog (Extended release naltrexone)

Completed
  • Opioid-use Disorder
  • Extended release naltrexone
  • Loerenskog, Akershus, Norway
    Akershus University Hospital
Nov 30, 2022

Sacroiliitis Trial (High-intensity focused ultrasound for Sacroiliitis using the Neurolyser XR)

Not yet recruiting
  • Sacroiliitis
  • High-intensity focused ultrasound for Sacroiliitis using the Neurolyser XR
  • (no location specified)
Sep 21, 2023

Korean Post-marketing Surveillance for Xeljanz XR

Recruiting
  • Active Moderate to Severe Rheumatoid Arthritis
  • Active Ankylosing Spondylitis
  • Tofacitinib XR
  • Seoul, Korea, Republic of
    Pfizer
Oct 10, 2022

JOURNEY II XR Safety and Effectiveness PMCF

Active, not recruiting
  • Rheumatoid Vasculitis With Rheumatoid Arthritis of Knee
  • +5 more
  • JOURNEY II XR Total Knee System
  • Loma Linda, California
  • +13 more
Sep 13, 2022

Healthy Volunteer Trial in Suzhou (Dapagliflozin/metformin XR FDC 5/500 mg, Dapagliflozin/metformin XR FDC 10/1000 mg,

Completed
  • Healthy Volunteer
  • Dapagliflozin/metformin XR FDC 5/500 mg
  • +3 more
  • Suzhou, China
    Research Site
Apr 25, 2022

Cocaine Use Disorder Trial (Extended-Release Naltrexone, Extended Release Buprenorphine, Placebo (PLB) Injectable)

Not yet recruiting
  • Cocaine Use Disorder
  • Extended-Release Naltrexone
  • +2 more
  • (no location specified)
Jul 15, 2022

Opioid-use Disorder Trial in United States (Standard Induction Procedure (SP), Rapid Induction Procedure (RP))

Active, not recruiting
  • Opioid-use Disorder
  • Standard Induction Procedure (SP)
  • Rapid Induction Procedure (RP)
  • Orlando, Florida
  • +5 more
Jul 19, 2022

Type 2 Diabetes Trial (ARM A, ARM B, ARM C)

Not yet recruiting
  • Type 2 Diabetes
  • ARM A
  • +5 more
  • (no location specified)
Dec 27, 2022

Opioid-use Disorder Trial in United States (XR-B (SUBLOCADETM), XR-NTX)

Recruiting
  • Opioid-use Disorder
  • New Haven, Connecticut
  • +5 more
Jan 28, 2022

Healthy Trial in Adelaide (TR-01-XRR (1), TR-01-XRR (2), TR-01-XRR (3))

Not yet recruiting
  • Healthy
  • TR-01-XRR (1)
  • +6 more
  • Adelaide, South Australia, Australia
    CMAX Clinical Research
Feb 3, 2023

Substance Use Disorder, Opioid Use Disorder, Moderate, Opioid Use Disorder, Severe Trial in United States (Extended Release

Recruiting
  • Substance Use Disorder
  • +2 more
  • Extended Release Buprenorphine
  • Treatment as Usual
  • New Haven, Connecticut
  • +4 more
Dec 21, 2022

Type 2 Diabetes Trial in Daejeon (CT-L01 12.5/500 mg, Alogliptin Benzoate 12.5 mg, Metformin HCl XR 500 mg)

Completed
  • Healthy
  • CT-L01 12.5/500 mg
  • +2 more
  • Daejeon, Korea, Republic of
    Chungnam National University Hospital
Jan 10, 2023

Type 2 Diabetes Trial in Daejeon (CT-L01, Alogliptin Benzoate 25 mg, Metformin HCl XR 1,000 mg)

Completed
  • Healthy
  • Daejeon, Korea, Republic of
    Chungnam National University Hospital
Jan 10, 2023

MDD, Generalized Anxiety Disorder Trial in New York (seroquel xr, CBT)

Completed
Has Results
  • Major Depressive Disorder
  • Generalized Anxiety Disorder
  • seroquel xr
  • CBT
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Jan 18, 2018

Attention Deficit/Hyperactivity Disorder Trial in New York (Centanafadine Hydrochloride)

Recruiting
  • Attention Deficit/Hyperactivity Disorder
  • Centanafadine Hydrochloride
  • New York, New York
    For additional information regarding sites, contact 844-687-8522
Aug 31, 2022

Sacroiliitis Trial in Givatayim (NeurolyserXR)

Not yet recruiting
  • Sacroiliitis
  • NeurolyserXR
  • Givatayim, Israel
    Sheba Medical Center
Jul 26, 2022

Elbow Fracture, Radial Head Fracture, Elbow Sprain Trial in Basel (POCUS)

Recruiting
  • Elbow Fracture
  • +4 more
  • POCUS
  • Basel, Switzerland
    Merian Iselin Klinik
Oct 26, 2022